Granulocyte Colony-stimulating Factor Improves Innate Immunity in Pediatric Pretransplant Patients

Dale, 2018, A systematic literature review of the efficacy, effectiveness, and safety of filgrastim, Support Care Cancer, 26, 7, 10.1007/s00520-017-3854-x Wang, 2015, The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials, Support Care Cancer, 23, 3131, 10.1007/s00520-015-2686-9 Jindal, 2022, Hepatic regeneration in cirrhosis, Journal of Clinical and Experimental Hepatology, 12, 603, 10.1016/j.jceh.2021.08.029 Verma, 2018, Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial, Hepatology, 68, 1559, 10.1002/hep.29763 Chavez-Tapia, 2015, Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis, Ann Hepatol, 14, 631, 10.1016/S1665-2681(19)30757-4 Simonetto, 2017, Improving survival in ACLF: growing evidence for use of G-CSF, Hepatol Int, 11, 473, 10.1007/s12072-017-9834-x Duan, 2013, Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure, World J Gastroenterol, 19, 1104, 10.3748/wjg.v19.i7.1104 Albillos, 2014, Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance, J Hepatol, 61, 1385, 10.1016/j.jhep.2014.08.010 Rahayatri, 2022, Granulocyte colony-stimulating factor therapy as a bridging treatment for pediatric decompensated liver cirrhosis prior to liver transplantation: an open-label randomized clinical trial, Bali Med J, 11, 1250, 10.15562/bmj.v11i3.3527 Oswari, 2020, Pediatric living donor liver transplant in Indonesia's national referral hospital, Transplantation, 104, 1305, 10.1097/TP.0000000000003154 Irvine, 2019, Causes and consequences of innate immune dysfunction in cirrhosis, Front Immunol, 10, 293, 10.3389/fimmu.2019.00293 Premkumar, 2022, Overview of complications in cirrhosis, J Clin Exp Hepatol, 12, 1150, 10.1016/j.jceh.2022.04.021 Mannaa, 2016, Physiological potential of cytokines and liver damages, Hepatoma Research, 2, 10.20517/2394-5079.2015.58 Dirchwolf, 2016, Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity, Cytokine, 77, 14, 10.1016/j.cyto.2015.10.006 Wilasco, 2017, IL-6, TNF-alpha, IL-10, and nutritional status in pediatric patients with biliary atresia, J Pediatr, 93, 517 Bernsmeier, 2020, Innate immune cells in cirrhosis, J Hepatol, 73, 186, 10.1016/j.jhep.2020.03.027 Lange, 2018, Immunodysfunction in acute-on-chronic liver failure, Visc Med, 34, 276, 10.1159/000488690 Piscaglia, 2007, Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats, Gastroenterology, 133, 619, 10.1053/j.gastro.2007.05.018 Yannaki, 2005, G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs, Exp Hematol, 33, 108, 10.1016/j.exphem.2004.09.005 Sharma, 2020, Role of granulocyte colony stimulating factor on the short-term outcome of children with acute on chronic liver failure, J Clin Exp Hepatol, 10, 201, 10.1016/j.jceh.2019.10.001 Baig, 2020, Efficacy of granulocyte colony stimulating factor in severe alcoholic hepatitis: a systematic review and meta-analysis, Cureus, 12 Philips, 2020, Granulocyte colony-stimulating factor use in decompensated cirrhosis: lack of survival benefit, J Clin Exp Hepatol, 10, 124, 10.1016/j.jceh.2019.05.003 Spahr, 2008, Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial, Hepatology, 48, 221, 10.1002/hep.22317 Lambertini, 2014, The five "Ws” for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs), Crit Rev Oncol Hematol, 89, 112, 10.1016/j.critrevonc.2013.08.006 Rathi, 2020, Granulocyte colony stimulating factor: a potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis, Ann Hepatol, 20 Sveikata, 2014, Comparison of the pharmacokinetic and pharmacodynamic properties of two recombinant granulocyte colony-stimulating factor formulations after single subcutaneous administration to healthy volunteers, Medicina (Kaunas), 50, 144, 10.1016/j.medici.2014.08.001